Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-07Clinical Trial Update: Rituximab (RTX) for Disease Modifying Anti Rheumatic Drug (DMARD) Non-responders in Pakistan: The Pakistan Rituximab Study (PARIS) [Phase 4]
Phase 4 clinical trial update on rituximab for rheumatoid arthritis patients who are non-responsive to DMARDs in Pakistan (PARIS study); the…
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Activity Limitations in Rheumatoid Arthritis
A clinical trial evaluating activity limitations in rheumatoid arthritis has completed. The study was sponsored by the Federal University of…
-
FDA approval · 2016-04-05FDA Approved: INFLECTRA — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved INFLECTRA (infliximab-dyyb) as a biosimilar to infliximab for multiple autoimmune diseases, expanding access to a biologic ther…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy
A completed clinical trial evaluated the safety, tolerability and efficacy of tocilizumab in rheumatoid arthritis patients who had an inadeq…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: An Observational Study in Clinical Practice Management of Patients With Biological Drugs in Monotherapy
This is a completed observational clinical-practice study examining how patients with rheumatoid arthritis are managed when treated with bio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: A Study of Tocilizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic DMARDs [Phase 3]
A Phase 3 trial evaluating tocilizumab in rheumatoid arthritis patients who had an inadequate response to non-biologic DMARDs has completed,…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs or Anti-TNF [Phase 3]
Phase 3 study of tocilizumab (RoActemra/Actemra) in rheumatoid arthritis patients with inadequate response to DMARDs or anti-TNF therapy com…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis [Phase 1]
Phase 1, single-dose study evaluating the safety of sarilumab and tocilizumab in rheumatoid arthritis. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis
This document reports the completion of a non-interventional study of RoActemra/Actemra in adults with moderate to severe rheumatoid arthrit…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: A Study of Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA) [Phase 1, Phase 2]
A Phase 1/2 study of ocrelizumab in adults with moderate to severe rheumatoid arthritis was terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis [Phase 3]
A Phase 3 clinical trial evaluating the addition of rituximab to leflunomide in patients with active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis [Phase 4]
A Phase 4 open-label study assessed whether early response to certolizumab pegol can predict longer-term outcomes in rheumatoid arthritis; r…
-
CLINICAL_TRIALS research · 2016-03-21Clinical Trial Update: Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis
This trial update compares bone cell activity between rheumatoid arthritis and ankylosing spondylitis, highlighting distinct patterns of bon…
-
FDA approval · 2016-03-18FDA Approved: ARTHRITIS PAIN RELIEVER — Original Application (CVS PHARMACY, INC)
FDA approves CVS Pharmacy, Inc.'s Arthritis Pain Reliever as an original generic application for diclofenac sodium. The product is an NSAID …
-
FDA approval · 2016-03-16FDA Approved: CELECOXIB — Original Application (McKesson Corporation dba SKY Packaging)
FDA approved the original Abbreviated New Drug Application for a generic celecoxib product manufactured by McKesson Corporation dba SKY Pack…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Effects of Underwater Ultrasound Therapy on Hand Function and Quality of Life in Patients With Rheumatoid Arthritis [NA]
A completed clinical trial evaluated underwater ultrasound therapy for hand function and quality of life in patients with rheumatoid arthrit…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Special Investigation in Patients With Rheumatoid Arthritis (HOPEFUL III Study), a Follow-up Survey of Study P12-069
Update on the HOPEFUL III rheumatoid arthritis study, a follow-up survey of Study P12-069, which has completed and posted its results. The d…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)
A completed study evaluating how to manage synthetic disease-modifying antirheumatic drugs when rheumatoid arthritis patients experience adv…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis [Phase 1]
This completed Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of multiple subcutaneous injections of ABBV-257 in sub…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Reciprocating Medical Devices - a Study of a New Safety Device [NA]
A completed clinical trial evaluating a new safety device was conducted, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: An Efficacy And Safety Study of CNTO 6785 In Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 2]
This Phase 2 trial update evaluates the efficacy and safety of CNTO 6785 in participants with active rheumatoid arthritis despite methotrexa…
-
FDA approval · 2016-02-29FDA Approved: LEFLUNOMIDE — Supplemental Application (Apotex Corp.)
FDA approves a supplemental application for Leflunomide by Apotex Corp., approving this generic product.
-
CLINICAL_TRIALS research · 2016-02-26Clinical Trial Update: Endothelial Dysfunction Evaluation for Coronary Heart Disease Risk Estimation in Rheumatoid Arthritis (EDRA Study)
Clinical trial update on the EDRA study evaluating endothelial dysfunction to estimate coronary heart disease risk in patients with rheumato…
-
FDA approval · 2016-02-25FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application to bring ALEVE GELCAPS (naproxen sodium) to market as a new dosage form from Bayer HealthCare LL…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Immunogenicity and Safety of Vaccinations in Immunocompromised Persons
This clinical trial update summarizes results on the immunogenicity and safety of vaccinations in immunocompromised individuals, including t…